
Zhongchao Inc. Class A Ordinary Shares
ZCMDZhongchao Inc. Class A Ordinary Shares (ZCMD) is a healthcare service company focused on providing medical information, patient management solutions, and other healthcare-related services primarily in China. The company leverages technology and digital platforms to improve healthcare delivery, facilitate medical consultations, and enhance patient experience.
Company News
Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for the year ended Dec 31, 2023. Reliance Global Group posted a net loss of $12.0 million for 2023, compared to net income of $6.5 million in 2022.. Reliance Global Group shares tumbled 11.3% to $0.47 in pre-mark...
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares. Flora Growth shares tumbled 20.2% to $2.13 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers HWH International Inc. (NASD...
Shares of SurgePays, Inc. (NASDAQ: SURG) fell sharply in today’s pre-market trading after the company reported worse-than-expected fourth-quarter financial results. Surgepays posted GAAP earnings of 19 cents per share, missing market estimates of 41 cents per share. The company’s quarterly sales came in at $32.318 million versus expectation...
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company’s quarterly sales came in at $17.05...
Shares of Paymentus Holdings, Inc. (NYSE: PAY) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth quarter financial results. Paymentus reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 7 cents per share. Quarterly sales clocked in at $164.8 million whic...


